N,N'-(2,2'-(3,3'-disulfanediylbis(5-oxo-2,3,4,5-tetrahydro-1,2,4-triazine-6,3-diyl))bis(4-fluoro-2,1-phenylene))bis(4-fluorobenzamide)

ID: ALA5285374

Max Phase: Preclinical

Molecular Formula: C32H22F4N8O4S2

Molecular Weight: 722.71

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(SSC2NN=C(c3cc(F)ccc3NC(=O)c3ccc(F)cc3)C(=O)N2)NN=C1c1cc(F)ccc1NC(=O)c1ccc(F)cc1

Standard InChI:  InChI=1S/C32H22F4N8O4S2/c33-17-5-1-15(2-6-17)27(45)37-23-11-9-19(35)13-21(23)25-29(47)39-31(43-41-25)49-50-32-40-30(48)26(42-44-32)22-14-20(36)10-12-24(22)38-28(46)16-3-7-18(34)8-4-16/h1-14,31-32,43-44H,(H,37,45)(H,38,46)(H,39,47)(H,40,48)

Standard InChI Key:  PIPBSFBCZFZDKX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 50 55  0  0  0  0  0  0  0  0999 V2000
   -3.2651    3.1847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5507    2.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8362    3.1847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1186    2.7704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4085    3.1868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4085    4.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3058    4.4203    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1232    4.4204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8362    4.0098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5507    1.9472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2651    1.5347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2651    0.7097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5507    0.2972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5507   -0.5313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2651   -0.9438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8342   -0.9394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1240   -0.5276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4095   -0.9401    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.3048   -0.5276    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9965   -0.9772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9965   -1.7969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6405   -2.2502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6405   -3.0741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3789   -1.8743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3789   -1.0504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7320   -0.6028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0706   -2.3239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0706   -3.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7143   -3.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7143   -4.4204    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.4957   -3.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4957   -2.3971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8058   -1.9496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8058   -1.1257    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5846   -0.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2763   -1.2010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5846    0.0723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9333    0.5239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9815    1.3469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7138    1.7180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7138    2.5419    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4058    1.2682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4058    0.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1240    0.2975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8360    0.7095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9751    0.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6913    0.7060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4058    0.2935    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6913    1.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9769    1.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9  3  2  0
 10  2  1  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  1  0
 21 20  1  0
 22 21  1  0
 22 23  2  0
 24 22  1  0
 25 24  2  0
 26 25  1  0
 20 26  1  0
 24 27  1  0
 28 27  1  0
 29 28  2  0
 29 30  1  0
 31 29  1  0
 32 31  2  0
 33 32  1  0
 27 33  2  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
 35 37  1  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  1  0
 40 42  2  0
 42 43  1  0
 43 37  2  0
 17 44  1  0
 44 45  1  0
 45 13  2  0
 46 12  1  0
 47 46  2  0
 47 48  1  0
 49 47  1  0
 50 49  2  0
 11 50  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5285374

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E (1410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 722.71Molecular Weight (Monoisotopic): 722.1142AlogP: 4.24#Rotatable Bonds: 9
Polar Surface Area: 165.18Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.17CX Basic pKa: CX LogP: 7.42CX LogD: 7.41
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.11Np Likeness Score: -0.59

References

1. Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G..  (2017)  An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.,  142  [PMID:28851503] [10.1016/j.ejmech.2017.08.009]

Source